• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Endocrinology

Reducing sugars in sweetened drinks may prevent up to 1 million adults from becoming obese in the UK

byStefan Trela
January 8, 2016
in Endocrinology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

 

1. This modeling study, conducted in the UK, estimated that gradually reducing the amount of free sugars added to sugar-sweetened drinks by 40% over five years would prevent 500,000 adults from becoming overweight and 1 million adults from becoming obese.

2. Additionally, removing free sugars would prevent approximately 300,000 cases of obesity-related type 2 diabetes.

Evidence Rating Level: 2 (Good)

Study Rundown: The consumption of sugar-sweetened drinks continues to rise and is the largest source of sugar for children and the second largest source for adults in the UK. Evidence has shown that consuming sugary drinks contributes to obesity in children and adults, and has been linked to an increased risk of type 2 diabetes. This modeling study sought to analyze the effect of reducing the amount of free sugars added to sugar-sweetened drinks by 9.7% per year with a goal of 40% reduction over five years. Data was used to calculate the consumption of sugar-containing beverages in the UK population, estimate the decrease in energy intake as a result of the proposal to reduce free sugar, and estimate the reduction in the number of overweight and obese adults and adults with type 2 diabetes in the UK population.

The results showed that a 40% reduction over five years in free sugars added to sugar-sweetened drinks would lead to 38.4 kcal per day less energy intake, resulting in a decrease in bodyweight by 1.2 kg in the long term. This would lead to 500,000 less overweight adults and 1 million less obese adults, a decrease by 1% and 2.1%, respectively, and prevent approximately 300,000 cases of obesity related type 2 diabetes over the next two decades. This study was strengthened by suggesting a stepwise approach to remove sugar that has already been successful with salt, but was limited by only using the model to predict weight change in adults rather than children.

RELATED REPORTS

Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial

2 Minute Medicine Rewind December 15, 2025

GLP-1 receptor agonists show little effect on obesity-related cancer risk

Click to read the study in The Lancet Diabetes & Endocrinology

Relevant Reading: Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013

In-Depth [prospective cohort]: This study utilized data from the National Diet and Nutrition Survey rolling program (NDNS RP) from 2008-12 and the British Soft Drinks Association to calculate sugar-sweetened beverage consumption in the UK population. The term “free sugars” included all monosaccharides and disaccharides added to soft drinks, and natural sugars in honey, syrups, and unsweetened fruit juices.

Reducing the amount of free sugars added to sugar-containing drinks by 40% over 5 years would lead to 38.4 kcal per day less energy intake (95% CI 36.3-40.7), corresponding to an average reduction in bodyweight of 1.20 kg (1.12-1.28). This reduction in bodyweight would result in a decreased prevalence in overweight adults from 35.5% to 34.5% and obese adults from 27.8% to 25.7%, and prevent 274,000-309,000 cases of type 2 diabetes. Additionally, in a separate analysis excluding fruit juices, the energy intake would decrease by 31.0 kcal per day (95% CI 28.6-33.7) and bodyweight would decrease by 0.96 kg (0.88-1.04). This would lead to 300,000 less overweight adults (0.7%) and 800,000 less obese adults (1.7%), and prevent 221,000-250,000 cases of type 2 diabetes.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetesobesity
Previous Post

Low sFlt-1-PlGF ratio linked to short-term absence of preeclampsia: The PROGNOSIS study

Next Post

Artesunate-amodiaquine therapy linked to lower Ebola mortality

RelatedReports

Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Chronic Disease

Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial

December 19, 2025
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Weekly Rewinds

2 Minute Medicine Rewind December 15, 2025

December 15, 2025
Many new pediatric asthma cases attributable to obesity
Chronic Disease

GLP-1 receptor agonists show little effect on obesity-related cancer risk

December 8, 2025
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Cardiology

Analysis of arrhythmia and its risk factors in patients with COVID-19

December 3, 2025
Next Post
2 Minute Medicine Rewind November 23 – November 30, 2014

Artesunate-amodiaquine therapy linked to lower Ebola mortality

Youth ice hockey concussion rate comparable to other sports

Youth ice hockey concussion rate comparable to other sports

Oral fluconazole in pregnancy associated with miscarriage

Oral fluconazole in pregnancy associated with miscarriage

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
  • Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry
  • Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.